The National Institutes of Health (NIH) in the United States announced the start of an early-stage research on an experimental vaccine targeting six strains of influenza virus. The vaccine candidate, FluMos-v2, is intended to protect against four...
vThe United States Food and Drug Administration (USFDA) has granted final approval to Zydus Lifesciences for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day (USRLD: Ortho Evra Transdermal System, 150 mcg/35 mcg per...
One of the most promising developments in the constantly developing field of medicine is pharmacologists.
Vial, a worldwide technology-driven CRO that provides next-generation clinical trial administration services, has joined forces with MLM Medical Labs ("MLM"), an international central and speciality laboratory with locations in Europe and North...
ICRA published its analysis of the local pharmaceutical market and predicted revenue increase of 8–10% for the fiscal year 2024. The Indian pharmaceutical industry (IPM) saw a solid compound annual growth rate (CAGR) of 9.7% between FY2014 and FY...
The launch of AlveoGene, a new UK-based biotech created to develop medicines based on a lentiviral vector technology developed by researchers from the UK Respiratory Gene Therapy Consortium (GTC) to deliver gene therapies directly into the lungs...
InnoCare Pharma has received IND approval to conduct a clinical trial in China of ICP-189, a novel SHP2 (Src Homology 2 domain containing protein tyrosine phosphatase) allosteric inhibitor, in combination with furmonertinib, a highly brain...
Sun Pharmaceutical Industries announced a collaboration with US-based Pharmazz Inc to commercialize a medication used to treat cerebral ischemic stroke in India. One of the business's wholly-owned subsidiaries has entered into a license deal with...
LifeSphere Safety has been selected by medac, a German-based pharmaceutical manufacturer specializing in oncology and hematology, urology, and autoimmune diseases, to modernize its drug safety processes, according to ArisGlobal, a market leader...
The Cabinet Committee on Economic Affairs has approved foreign investment in Suven Pharmaceuticals by Cyprus-based Berhyanda Limited up to Rs 9,589 crore. Berhyanda has been granted permission by the Cabinet to acquire up to 76.1 percent of the...